Abacavir/lamivudine
(Redirected from Kivexa)
What Is Abacavir/lamivudine ?[edit | edit source]
Abacavir and lamivudine tablets, a combination of abacavir and lamivudine, both nucleoside analogue HIV-1 reverse transcriptase inhibitors.
What are the uses of this medicine?[edit | edit source]
- Abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.
How does this medicine work?[edit | edit source]
- Abacavir and lamivudine is an antiretroviral agent
- Abacavir, lamivudine are in a class of medications called nucleoside reverse transcriptase inhibitors (NRTIs).
- They work by decreasing the amount of HIV in the blood.
Who Should Not Use this medicine ?[edit | edit source]
This medicine cannot be used in:
- who have the HLA-B*5701 allele
- with prior hypersensitivity reaction to abacavir or lamivudine.
- with moderate or severe hepatic impairment
Is this medicine FDA approved?[edit | edit source]
- Abacavir/lamivudine was approved for medical use in the United States in 2004.
- It is on the World Health Organization's List of Essential Medicines.
How should this medicine be used?[edit | edit source]
Before initiating abacavir and lamivudine tablets, screen for the HLA-B*5701 allele because abacavir and lamivudine tablets contains abacavir.
Adults: The recommended dosage of abacavir and lamivudine tablets for adults is one tablet taken orally once daily, in combination with other antiretroviral agents, with or without food.
Pediatric patients weighing at least 25 kg: The recommended oral dose of abacavir and lamivudine for pediatric patients weighing at least 25 kg is one tablet daily in combination with other antiretroviral agents.
- Because abacavir and lamivudine tablet is a fixed-dose tablet and cannot be dose adjusted, abacavir and lamivudine tablets are not recommended in patients requiring dosage adjustment or patients with hepatic impairment.
What are the dosage forms and brand names of this medicine?[edit | edit source]
This medicine is available in fallowing doasage form:
- Abacavir and lamivudine tablets USP 600 mg/300 mg contain 600 mg of abacavir as abacavir sulfate and 300 mg of lamivudine.
This medicine is available in fallowing brand names:
- EPIVIR, TRIUMEQ, TRIZIVIR, and ZIAGEN
What side effects can this medication cause?[edit | edit source]
Common possible side effects of this medicine include:
- hypersensitivity
- insomnia
- depression/depressed mood
- headache/migraine
- fatigue/malaise
- dizziness/vertigo
- nausea
- diarrhea
What special precautions should I follow?[edit | edit source]
- All patients should be screened for the HLA-B*5701 allele prior to initiating therapy with abacavir and lamivudine or reinitiation of therapy .
- Before starting abacavir and lamivudine, review medical history for prior exposure to any abacavir-containing product.
- Discontinue abacavir and lamivudine immediately if a hypersensitivity reaction is suspected, even when other diagnoses are possible (e.g., acute onset respiratory diseases such as pneumonia, bronchitis, pharyngitis, or influenza; gastroenteritis; or reactions to other medications).
- Treatment with abacavir and lamivudine should be suspended in any patient who develops clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity, which may include hepatomegaly and steatosis even in the absence of marked transaminase elevations.
- Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy.
What to do in case of emergency/overdose?[edit | edit source]
- There is no known specific treatment for overdose with abacavir and lamivudine.
- If overdose occurs, the patient should be monitored, and standard supportive treatment applied as required.
Abacavir: It is not known whether abacavir can be removed by peritoneal dialysis or hemodialysis.
Lamivudine: Because a negligible amount of lamivudine was removed via (4-hour) hemodialysis.it is not known if continuous hemodialysis would provide clinical benefit in a lamivudine overdose event.
Can this medicine be used in pregnancy?[edit | edit source]
- Safety in pregnancy has not been well studied but it appears to be okay.
Can this medicine be used in children?[edit | edit source]
- In pediatric patients weighing less than 25 kg, use of abacavir and lamivudine as single products is recommended to achieve appropriate dosing.
What should I know about storage and disposal of this medication?[edit | edit source]
- Store abacavir and lamivudine tablets at 20° to 25°C (68° to 77°F).
Abacavir/lamivudine Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD